The 10 most popular stories in Endpoints News — so far in 2017
Since Arsalan Arif and I ramped up the main edition of Endpoints News 16 months ago, we’ve published more than a million words on biopharma R&D.
Tolstoy, eat your heart out.
This year we’ve increased web traffic, tracking close to an average of 20,000 readers per day — with more than 22,000 email subscribers — which is considerably higher than where we started in the middle of 2016.
So what are biopharma people reading in Endpoints?
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.